Cargando…

Physical activity and activity space in patients with pulmonary fibrosis not prescribed supplemental oxygen

BACKGROUND: Patients with pulmonary fibrosis (PF) have impaired quality of life, and research suggests that dyspnea and physical activity are primary drivers. As PF progresses, some patients notice the disease “shrinks their worlds”. The objective of this study is to describe movement (both physical...

Descripción completa

Detalles Bibliográficos
Autores principales: Root, Elisabeth Dowling, Graney, Bridget, Baird, Susan, Churney, Tara, Fier, Kailtin, Korn, Majorie, McCormic, Mark, Sprunger, David, Vierzba, Tomas, Wamboldt, Frederick S., Swigris, Jeffery J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5701349/
https://www.ncbi.nlm.nih.gov/pubmed/29169394
http://dx.doi.org/10.1186/s12890-017-0495-2
_version_ 1783281317921685504
author Root, Elisabeth Dowling
Graney, Bridget
Baird, Susan
Churney, Tara
Fier, Kailtin
Korn, Majorie
McCormic, Mark
Sprunger, David
Vierzba, Tomas
Wamboldt, Frederick S.
Swigris, Jeffery J.
author_facet Root, Elisabeth Dowling
Graney, Bridget
Baird, Susan
Churney, Tara
Fier, Kailtin
Korn, Majorie
McCormic, Mark
Sprunger, David
Vierzba, Tomas
Wamboldt, Frederick S.
Swigris, Jeffery J.
author_sort Root, Elisabeth Dowling
collection PubMed
description BACKGROUND: Patients with pulmonary fibrosis (PF) have impaired quality of life, and research suggests that dyspnea and physical activity are primary drivers. As PF progresses, some patients notice the disease “shrinks their worlds”. The objective of this study is to describe movement (both physical activity and activity space) in a cohort of patients with PF of various etiologies who have not been prescribed supplemental oxygen (O(2)). METHODS: Subjects with PF not on supplemental O(2) during the day were enrolled from across the U.S. from August 2013 to October 2015. At enrollment, each subject completed questionnaires and, for seven consecutive days, wore an accelerometer and GPS tracker. RESULTS: One hundred ninety-four subjects had a confirmed diagnosis of PF and complete, analyzable GPS data. The cohort was predominantly male (56%), Caucasian (95%) and had idiopathic pulmonary fibrosis (30%) or connective tissue disease related-PF (31%). Subjects walked a median 7497 (interquartile range [IQR] 5766-9261) steps per day. Steps per day were correlated with symptoms and several quality of life domains. In a model controlling for age, body mass index, wrist- (vs. waist) worn accelerometer and percent predicted diffusing capacity (DLCO%), fatigue (beta coefficient = −51.5 ± 11.7, p < 0.0001) was an independent predictor of steps per day (model R(2)=0.34). CONCLUSIONS: Patients with PF, who have not been prescribed O(2) for use during the day, have wide variability in their mobility. Day-to-day physical activity is related to several domains that impact quality of life, but GPS-derived activity space is not. Wearable data collection devices may be used to determine whether and how therapeutic interventions impact movement in PF patients. TRIAL REGISTRATION: NCT01961362. Registered 9 October, 2013. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s12890-017-0495-2) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-5701349
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-57013492017-12-01 Physical activity and activity space in patients with pulmonary fibrosis not prescribed supplemental oxygen Root, Elisabeth Dowling Graney, Bridget Baird, Susan Churney, Tara Fier, Kailtin Korn, Majorie McCormic, Mark Sprunger, David Vierzba, Tomas Wamboldt, Frederick S. Swigris, Jeffery J. BMC Pulm Med Research Article BACKGROUND: Patients with pulmonary fibrosis (PF) have impaired quality of life, and research suggests that dyspnea and physical activity are primary drivers. As PF progresses, some patients notice the disease “shrinks their worlds”. The objective of this study is to describe movement (both physical activity and activity space) in a cohort of patients with PF of various etiologies who have not been prescribed supplemental oxygen (O(2)). METHODS: Subjects with PF not on supplemental O(2) during the day were enrolled from across the U.S. from August 2013 to October 2015. At enrollment, each subject completed questionnaires and, for seven consecutive days, wore an accelerometer and GPS tracker. RESULTS: One hundred ninety-four subjects had a confirmed diagnosis of PF and complete, analyzable GPS data. The cohort was predominantly male (56%), Caucasian (95%) and had idiopathic pulmonary fibrosis (30%) or connective tissue disease related-PF (31%). Subjects walked a median 7497 (interquartile range [IQR] 5766-9261) steps per day. Steps per day were correlated with symptoms and several quality of life domains. In a model controlling for age, body mass index, wrist- (vs. waist) worn accelerometer and percent predicted diffusing capacity (DLCO%), fatigue (beta coefficient = −51.5 ± 11.7, p < 0.0001) was an independent predictor of steps per day (model R(2)=0.34). CONCLUSIONS: Patients with PF, who have not been prescribed O(2) for use during the day, have wide variability in their mobility. Day-to-day physical activity is related to several domains that impact quality of life, but GPS-derived activity space is not. Wearable data collection devices may be used to determine whether and how therapeutic interventions impact movement in PF patients. TRIAL REGISTRATION: NCT01961362. Registered 9 October, 2013. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s12890-017-0495-2) contains supplementary material, which is available to authorized users. BioMed Central 2017-11-23 /pmc/articles/PMC5701349/ /pubmed/29169394 http://dx.doi.org/10.1186/s12890-017-0495-2 Text en © The Author(s). 2017 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research Article
Root, Elisabeth Dowling
Graney, Bridget
Baird, Susan
Churney, Tara
Fier, Kailtin
Korn, Majorie
McCormic, Mark
Sprunger, David
Vierzba, Tomas
Wamboldt, Frederick S.
Swigris, Jeffery J.
Physical activity and activity space in patients with pulmonary fibrosis not prescribed supplemental oxygen
title Physical activity and activity space in patients with pulmonary fibrosis not prescribed supplemental oxygen
title_full Physical activity and activity space in patients with pulmonary fibrosis not prescribed supplemental oxygen
title_fullStr Physical activity and activity space in patients with pulmonary fibrosis not prescribed supplemental oxygen
title_full_unstemmed Physical activity and activity space in patients with pulmonary fibrosis not prescribed supplemental oxygen
title_short Physical activity and activity space in patients with pulmonary fibrosis not prescribed supplemental oxygen
title_sort physical activity and activity space in patients with pulmonary fibrosis not prescribed supplemental oxygen
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5701349/
https://www.ncbi.nlm.nih.gov/pubmed/29169394
http://dx.doi.org/10.1186/s12890-017-0495-2
work_keys_str_mv AT rootelisabethdowling physicalactivityandactivityspaceinpatientswithpulmonaryfibrosisnotprescribedsupplementaloxygen
AT graneybridget physicalactivityandactivityspaceinpatientswithpulmonaryfibrosisnotprescribedsupplementaloxygen
AT bairdsusan physicalactivityandactivityspaceinpatientswithpulmonaryfibrosisnotprescribedsupplementaloxygen
AT churneytara physicalactivityandactivityspaceinpatientswithpulmonaryfibrosisnotprescribedsupplementaloxygen
AT fierkailtin physicalactivityandactivityspaceinpatientswithpulmonaryfibrosisnotprescribedsupplementaloxygen
AT kornmajorie physicalactivityandactivityspaceinpatientswithpulmonaryfibrosisnotprescribedsupplementaloxygen
AT mccormicmark physicalactivityandactivityspaceinpatientswithpulmonaryfibrosisnotprescribedsupplementaloxygen
AT sprungerdavid physicalactivityandactivityspaceinpatientswithpulmonaryfibrosisnotprescribedsupplementaloxygen
AT vierzbatomas physicalactivityandactivityspaceinpatientswithpulmonaryfibrosisnotprescribedsupplementaloxygen
AT wamboldtfredericks physicalactivityandactivityspaceinpatientswithpulmonaryfibrosisnotprescribedsupplementaloxygen
AT swigrisjefferyj physicalactivityandactivityspaceinpatientswithpulmonaryfibrosisnotprescribedsupplementaloxygen